Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aksara Global Development Tbk. (GAMA) vs Millennium Pharmacon International Tbk. (SDPC) Price & Performance

Aksara Global Development Tbk.Trade
Millennium Pharmacon International Tbk.Trade

Price performance (Past 24H)

Key statistics

Aksara Global Development Tbk. vs Millennium Pharmacon International Tbk. — how do they compare? Aksara Global Development Tbk. trades at Rp18 (market cap 180.2B), while Millennium Pharmacon International Tbk. trades at Rp196 (market cap 252.25B, 123.4K 24h volume). The key difference: Millennium Pharmacon International Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

GAMASDPC
Market Cap
180.2B252.25B
Volume
123.4K
Lot
1.23K
Turnover
24.17M
Average Price
195.88
Value
24.17M
Indicative Equilibrium Price
196
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SDPC
View details

About Aksara Global Development Tbk.

PT Gading Development Tbk (formerly PT Artha Asia Pratama) was established based on notarial deed No. 45 dated December 18, 2003 of P. Sutrisno A. Tampubolon, S.H., M.Kn., notary in Jakarta.

Read more on GAMA

About Millennium Pharmacon International Tbk.

PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.

Read more on SDPC